Answers are grounded in this paper and cite their sources.
The poor aqueous solubility, chemical instability, and concentration-dependent cytotoxicity of quercetin limit its practical application. Here, a hierarchical delivery platform was developed by incorporating amine-functionalized fluorescent mesoporous silica nanoparticles (FMSN-NH2) into a gelatin methacryloyl (GelMA) matrix. Pore expansion followed by surface functionalization increased the quercetin loading capacity approximately seven-fold, and preloading quercetin into the particles reduced its apparent loss during hydrogel fabrication from 60.1% to 18.5%. FMSN-NH2 served as the primary loading and release-regulating reservoir, restricting release at pH 7.4 to approximately 45% of the loaded quercetin, whereas a sufficiently dense GelMA network further reduced this fraction to approximately 25% and extended release under acidic conditions from 12 to 72 h. The released quercetin retained radical-scavenging activity, with the composite maintaining 51.2% DPPH activity at 96 h. In 3T3-L1 preadipocytes, encapsulation substantially reduced the cytotoxicity of free quercetin at an equivalent nominal dose. All encapsulated formulations attenuated H2O2-induced intracellular ROS to the basal level of untreated cells. As a proof of concept, a single administration of Q@FMSN-NH2@GelMA reduced lipid accumulation during adipogenic differentiation more effectively than either single-carrier formulation. In addition, it avoided the extensive cell loss observed with free quercetin. The newly developed FMSN-NH2 enables high-capacity cargo loading and release regulation, and GelMA functions as a particle reservoir that extends cargo availability.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: